explore -WSS

explore

author：comprehensive 2025-09-29 01:46:09 - browse：9

Verve Therapeutics CEO Sekar Kathiresan Verve

SAN FRANCISCO — The promise of genome editing has given rise to potentially curative medicines for rare, life-threatening diseases that generally affect small numbers of patients. But since Verve Therapeutics was founded in 2018, it’s had a wider aperture: using the molecular tools of genome editing to go after the most common cause of death in the world.

The plan, according to Verve CEO Sekar Kathiresan, is to edit out heart attacks for the millions of people at risk for severe cardiovascular disease. It’s a goal that’s more than a little audacious. There’s just one approved genome editing medicine, a treatment for sickle cell disease, and it only passed Food and Drug Administration review last month. Base editing, the CRISPR successor Verve uses to conduct its molecular surgery, is only a few years old.

“When we started, there were so many things that we were kind of going against the grain on,” Kathiresan told STAT at the J.P. Morgan Healthcare Conference in San Francisco this week. “In 2018, it was all about platforms, not about specific diseases and products, or taking this kind of idea for a large indication as opposed to cancer or rare disease. But we’ve always been motivated by a deep conviction in one simple research insight, which is that if your blood cholesterol is really low, lifelong, it is very hard to get a heart attack.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Judge denies Trump's request for new trial in E. Jean Carroll case

WSS

FTC falls short on scrutinizing hospital mergers, study says

More tobacco lobbyists active in statehouses

Scientists grapple with ethics of stem cell research

Dementia risk linked to living in disadvantaged areas: Study

Mystery swirls around US soldier who entered North Korea days ago, officials say

A new ‘biological computer' targets cancer while sparing healthy cells

leisure time

explore

hotspot

Continuity nursing helped my family in our darkest PICU moments

5 dead in mass shooting on Caribbean island of St. Vincent: Police

DIEP, the 'gold standard' of breast reconstruction, is under threat

Key Senate committee drafts bipartisan bill to stem drug shortages

Hepatitis C has a cure — but many Americans still lack access to it

Dogs on Prozac: What pet anti

Medical records are filled with copy

After a decade, new Gardasil ad campaign gets it (mostly) right

Virginia high school admissions case could be legal follow

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

hotspot

The stock market has soared this year, but will it last? Experts weigh in

Melinda French Gates resigns from Gates Foundation

Why rehabilitation engineers need to center patients in their research

Why rehabilitation engineers need to center patients in their research

Extensive review finds private equity owners jack up cost of care

Dementia risk linked to living in disadvantaged areas: Study

Wikipedia

entertainment

focus

hotspot